| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/20/2002 | US20020076457 Extracts of plants of genus Euphorbia, in particular sap of Euphorbia peplus, Euphorbia hirta and/or Euphorbia drummondii; selective cytotoxicity against malignant melanomas and squamous cell carcinomas |
| 06/20/2002 | US20020076456 Compositions and methods of use for extracts of magnoliaceae plants |
| 06/20/2002 | US20020076452 Provides synergistic anti-inflammatory effects in response to physical or chemical injury or abnormal immune stimulation; first component a sesquiterpene lactone species, diterpene lactone and a triterpene species as second component |
| 06/20/2002 | US20020076451 Health food product comprising cholic acid and isoflavone and/or isoflavone glycoside |
| 06/20/2002 | US20020076448 Anti-snoring composition |
| 06/20/2002 | US20020076447 Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticle, and therapeutic agent for treating zinc deficiency |
| 06/20/2002 | US20020076436 Compressed tablet formulation |
| 06/20/2002 | US20020076435 Capsule prepared from a omeprazole or its alkaline salt , an oily compound or salt, an emulsifier selected from organic fatty acid and an organic amine, a polycarbon alcohol; and an enteric coating on the outer layer of the capusle |
| 06/20/2002 | US20020076434 Liposomal retinoid therapy in hormone refractory prostate cancer |
| 06/20/2002 | US20020076433 Breath freshening comestible product and method of controlling breath malodor |
| 06/20/2002 | US20020076432 Encapsulated long chain alcohols |
| 06/20/2002 | US20020076423 Cosmetic or dermatological formulations for the care and cooling of the skin after sunbathing |
| 06/20/2002 | US20020076422 Improved foaming, stability and aesthetics; for applying retinol to skin; drug delivery |
| 06/20/2002 | US20020076421 Oral liquid mucoadhesive compositions |
| 06/20/2002 | US20020076417 Mutated pathogenic bacteria strains; gene expression |
| 06/20/2002 | US20020076399 Treatment of immune diseases |
| 06/20/2002 | US20020076398 Administering an agent that enhances Cyclic AMP response element binding protein (CREB) pathway function, training the animal to improve performance in the cognitive task; for people with central nervous system disorders |
| 06/20/2002 | US20020076395 Modified adipose tissue and related implants and methods |
| 06/20/2002 | US20020076393 By exposing eukaryotic cells to isoleucine or active isomers or analogs thereof |
| 06/20/2002 | US20020076389 Cosmetic and dermatological preparation with a content of cyclodextrins for the removal of sebum |
| 06/20/2002 | US20020076382 As well as drug delivery devices and dosage forms |
| 06/20/2002 | US20020076381 Novel compositions for use in embolizing blood vessels |
| 06/20/2002 | US20020073891 Light stabilized antimicrobial materials |
| 06/20/2002 | DE10145910A1 Ophtalmologische Formulierung mit verlangsamter Freisetzung und langer Verweildauer sowie Herstellungsverfahren hierfür Ophthalmic formulation with delayed release and long residence time and manufacturing method thereof |
| 06/20/2002 | DE10063224A1 Drug formulation useful e.g. for treating angina or hypertension contains pyrazolo (4,3-d) pyrimidine derivative phosphodiesterase V inhibitor and antithrombotic agent, calcium antagonist or prostaglandin |
| 06/20/2002 | DE10063223A1 Drug formulation useful e.g. for treating angina or hypertension contains thieno (2,3-d) pyrimidine derivative phosphodiesterase V inhibitor and antithrombotic agent, calcium antagonist or prostaglandin, |
| 06/20/2002 | DE10063221A1 Pharmaceutical formulation containing phosphodiesterase V inhibitor, preferably benzothienopyrimidine derivative, and antithrombotic agent, useful e.g. for treating pulmonary hypertension or congestive heart failure |
| 06/20/2002 | DE10063173A1 Harnstoff- und Urethanderivate Urea and urethane |
| 06/20/2002 | DE10063008A1 Carbonsäureamidderivate Carboxamide |
| 06/20/2002 | DE10062712A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden New pharmaceutical compositions based on anticholinergics and corticosteroids |
| 06/20/2002 | DE10062401A1 Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA Use of folic acid and / or derivatives thereof for producing cosmetic or dermatological preparations for the prevention of damage to the skin's DNA and / or repair of already occurred damage to the skin's DNA |
| 06/20/2002 | DE10061876A1 Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Arylated furan and thiophenecarboxamides, processes for their preparation, their use as a medicine and pharmaceutical compositions containing them |
| 06/20/2002 | DE10061161A1 Neue humane Androgenrezeptor-Varianten New human androgen receptor variants |
| 06/20/2002 | DE10060810A1 Coniosetin und Derivate davon, Verfahren zur Herstellung und Verwendung derselben Coniosetin and derivatives thereof, methods of making and using the same |
| 06/20/2002 | DE10060809A1 Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker Substituted anthranilic acids, their use as a medicament or diagnostic, and she containing drug, as well as a pharmaceutical combination preparation with a sodium / hydrogen exchange (NHE) blockers |
| 06/20/2002 | DE10060807A1 Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Ortho, ortho-substituted nitrogen-containing Bisarylverbindungen, processes for their preparation, their use as a medicine as well as pharmaceutical compositions containing them |
| 06/20/2002 | DE10060677A1 Klainetine und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben Klainetins and their derivatives, process for their preparation and use thereof |
| 06/20/2002 | DE10060292A1 Verwendung substituierter Benzimidazole zur Herstellung eines Medikaments zur Behandlung von Krankheiten, welche durch Inhibierung des Na+/H+-Austauschers beeinflusst werden können und sie enthaltendes Medikament Use of substituted benzimidazoles for the manufacture of a medicament for the treatment of diseases which can be influenced by inhibiting the Na + / H + exchanger and containing medicament |
| 06/20/2002 | DE10059418A1 Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Ortho, meta-substituted Bisarylverbindungen, processes for their preparation, their use as a medicine as well as pharmaceutical compositions containing them |
| 06/20/2002 | DE10059413A1 Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for the therapy of urinary incontinence |
| 06/20/2002 | CA2447900A1 Drug delivery compositions and medical devices containing block copolymer |
| 06/20/2002 | CA2445091A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 06/20/2002 | CA2436830A1 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | CA2431896A1 Compound |
| 06/20/2002 | CA2431766A1 Carboxymide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 06/20/2002 | CA2431747A1 Treatment of male sexual dysfunction |
| 06/20/2002 | CA2431709A1 Use of low molecular heparin for treating osteoarthritis |
| 06/20/2002 | CA2431663A1 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent |
| 06/20/2002 | CA2431406A1 Quinazolinone derivatives |
| 06/20/2002 | CA2431328A1 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile |
| 06/20/2002 | CA2431326A1 Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors |
| 06/20/2002 | CA2431287A1 Method and apparatus for treating breakthrough pain |
| 06/20/2002 | CA2431250A1 Composition for regulating animal growth, method of manufacture and use thereof |
| 06/20/2002 | CA2431172A1 Nmda receptor antagonist pharmaceutical compositions |
| 06/20/2002 | CA2431107A1 Antitumoral carbazoles |
| 06/20/2002 | CA2431095A1 Arylated furan- and thiophenecarboxamides, with potassium channel-blocking action |
| 06/20/2002 | CA2431044A1 Oral compositions and use thereof |
| 06/20/2002 | CA2430992A1 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 06/20/2002 | CA2430764A1 Blood lipid ameliorant composition |
| 06/20/2002 | CA2430760A1 Antilipemic agents |
| 06/20/2002 | CA2430458A1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 06/20/2002 | CA2430454A1 Cddo-compounds and combination therapies thereof |
| 06/20/2002 | CA2430415A1 Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia |
| 06/20/2002 | CA2430151A1 Phenylacetamido- pyrazole derivatives and their use as antitumor agents |
| 06/20/2002 | CA2429951A1 Antimicrobial quinolones |
| 06/20/2002 | CA2429352A1 Antiviral agents for treatment of flaviviridae infections |
| 06/20/2002 | CA2427872A1 Antimicrobial 2-pyridones, their compositions and uses |
| 06/20/2002 | CA2364984A1 Compositions comprising beta glucan and lactoferrin, and methods for their use |
| 06/19/2002 | EP1215497A1 Diagnostics for transmissible spongiform encephalopathy |
| 06/19/2002 | EP1215283A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
| 06/19/2002 | EP1215257A2 Warming composition |
| 06/19/2002 | EP1215213A2 Bicyclic amino-pyrazone derivatives, their preparation and pharmaceutical compositions containing them |
| 06/19/2002 | EP1215212A2 Dihydro derivatives of LL-E33288 antibiotics |
| 06/19/2002 | EP1215210A2 Benzofurans |
| 06/19/2002 | EP1215207A2 Salts of isoleucyl-thiazolidine and -pyrrolidine and their use as dipeptidylpeptidase inhibitors |
| 06/19/2002 | EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 06/19/2002 | EP1214948A2 Antibacterial composition for controlling airborne bacteria and corresponding procedure |
| 06/19/2002 | EP1214945A2 Method and medicament for inhibiting the expression of a defined gene |
| 06/19/2002 | EP1214944A1 Percutaneous absorption agents |
| 06/19/2002 | EP1214943A1 T-cell therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 06/19/2002 | EP1214940A1 Methods of enhancing the therapeutic activity of NSAIDs and compositions of zwitterionic phospholipids useful therein |
| 06/19/2002 | EP1214939A1 PPAR$g(a) AND PPAR$g(g) INHIBITORS |
| 06/19/2002 | EP1214938A2 Modulation of cellular response to external stimuli |
| 06/19/2002 | EP1214937A2 Terfenadine carboxylate and the treatment of dermal irritation |
| 06/19/2002 | EP1214936A2 Use of thiazolidin- or pyrrolidin-derivatives of aminoacids as antihyperglycemic agents |
| 06/19/2002 | EP1214933A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 06/19/2002 | EP1214931A1 Water-free skin care formulations comprising micronized urea and method of manufacturing the same |
| 06/19/2002 | EP1214927A1 Use of folic acid and/or its derivatives for the manufacture of topical compositions |
| 06/19/2002 | EP1214926A1 Topical composition |
| 06/19/2002 | EP1214925A1 Chemical peeling agent |
| 06/19/2002 | EP1214893A1 Health promoting compositions |
| 06/19/2002 | EP1214879A2 Antifungal fragrance composition |
| 06/19/2002 | EP1214599A2 Screening for alpha2delta-1 subunit binding ligands |
| 06/19/2002 | EP1214598A2 Screening for inhibitors of "paired helical filaments" |
| 06/19/2002 | EP1214589A1 Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures |
| 06/19/2002 | EP1214453A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 06/19/2002 | EP1214452A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 06/19/2002 | EP1214440A2 Sequence-specific dna recombination in eukaryotic cells |
| 06/19/2002 | EP1214422A1 Phosphatases which activate map kinase pathways |
| 06/19/2002 | EP1214417A2 Nucleic acids and proteins from group b streptococcus |